In recent studies, Zhang et al. [114,115,116] also illustrated the association between G6PD activity and RCC progression, proliferation, and the migration rate, focusing on MMP2 and MMP9 activity and expression. This evidence concerns the gene G6PD and renal cell adenocarcinoma.